A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen
Clinical trial NCT07099794 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07099794
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2029-02-28
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.